Objectives: To examine the incremental identification of emotional distress in mothers of hospitalized newborns by screening for anxiety in addition to depression and to provide practical information about anxiety screening scales to facilitate instrument selection and screening implementation by nurses in the NICU.
Accepted January 2017 I n 2016, the U.S. Preventive Services Task Force revised the recommendation to screen all adults for depression by adding a specification for pregnant and postpartum women (Siu & U.S. Preventive Services Task Force, 2016) . This specification was based on Grade B evidence, which indicates high certainty of moderate benefit of screening or moderate certainty of substantial benefit of screening. Because the Patient Protection and Affordable Care Act requires implementation of all U.S. Preventive Services Task Force recommendations that are based on Grade B evidence or greater, depression screening in the perinatal period is now federally required (Rhodes & Segre, 2013) . This formal development represents a major step forward in policy and clinical practice. Nevertheless, an exclusive focus on the identification of depression symptoms may mean that clinically significant emotional distress that manifests in the form of anxiety symptoms is missed. Indeed, previous researchers highlighted the comorbidity of depression and anxiety among women in the perinatal period (Navarro et al., 2008) and showed that a noteworthy percentage of those diagnosed with an anxiety disorder would be missed by depression-only screening (Matthey, 2008) . Although the current federal mandate does not include recommendations for anxiety screening, the International Marcé Society, an interdisciplinary group focused on perinatal mental health, highlighted the need for broader assessment, including anxiety symptoms (Austin & Marcé Society Postion Statement Advisory Committee, 2014) .
Hospitalization of a newborn in the NICU is often an unanticipated event that results in a myriad of stressful experiences. These experiences include but are not limited to concern caused by the immature physical appearance of the newborn; worry about the newborn's well-being; perceived loss of the maternal role to nurses and physicians; financial stressors associated with hospital costs; exposure to unfamiliar, highly technological equipment; distressing signs and sounds; and lack of familiarity with medical terminology (Tahirkheli, Cherry, Tackett, McCaffree, & Gillaspy, 2014) . Screening mothers of newborns in the NICU for the presence of clinically significant emotional distress is critical to ensure that they receive adequate support and appropriate referrals for treatment. Indeed, a number of efficacious psychosocial interventions have been identified for use with mothers of newborns in the NICU (Welch & Myers, 2016) .
Among mothers of premature newborns who are hospitalized in the NICU, prevalence estimates for clinically significant depression symptoms range from 25.5% to 63% (Segre, McCabe, Chuffo-Siewert, & O'Hara, 2014; Shelton, Meaney-Delman, Hunter, & Lee, 2014) . Given the comorbidity of anxiety and depression symptoms in perinatal women (Navarro et al., 2008) combined with the significant stressor of having a hospitalized newborn (Tahirkheli et al., 2014) , it is not surprising that state anxiety symptoms are also prevalent among mothers of newborns in the NICU. In a recent study of 232 mothers, 57% reported elevated levels of state anxiety symptoms at newborn admission (Holditch-Davis et al., 2015) . Similarly, in a study of 200 mothers of newborns in the NICU, 27.7% reported significant state anxiety symptoms in the moderate to severe range (Segre et al., 2014) . In studies with control groups of mothers of term newborns, rates of anxiety symptoms were significantly greater among mothers of newborns in the NICU (Brandon et al., 2011; Vanderbilt, Bushley, Young, & Frank, 2009 ). Moreover, several investigators reported greater prevalence rates of acute stress disorder in this population of women, ranging from 28% to 32% (Jubinville, Newburn-Cook, Hegadoren, & Lacaze-Masmonteil, 2012; Lefkowitz, Baxt, & Evans, 2010; Shaw et al., 2006) .
The prevalence of anxiety symptoms in mothers of hospitalized infants and the omission of anxiety screening recommendations from the National Perinatal Association (Hall et al., 2015) are the basis for the present study. Our overarching aim in this article is to describe strategies to expand extant depression screening protocols to include the assessment of anxiety symptoms. Specifically, based on secondary analysis of data collected from 190 mothers of hospitalized newborns during the recruitment phase of a NICU-based depression treatment trial (Segre, Chuffo-Siewert, Brock, & O'Hara, 2013) , we examined the incremental identification of emotional distress afforded by the addition of three different state anxiety screening scales to the widely used depression screening tool: the Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden, & Sagovsky, 1987) . Secondarily, we provide practical information about these three anxiety screening scales to facilitate instrument selection and screening implementation by nurses who work in NICUs.
Methods

Participants and Procedure
The method and study design of the original depression treatment trial are described in detail elsewhere . Briefly, mothers of hospitalized infants who were 18 years of age and older were recruited from a Level IV NICU at a large academic medical center in the Midwestern United States. Interested participants completed measures to assess emotional distress, and those with elevated depression symptoms were offered enrollment in a feasibility trial of a nurse-delivered counseling intervention. The present analyses were conducted on the screening data from this feasibility trial. Of the 200 women who completed initial assessment, 190 completed all screening measures. All procedures were approved by the University of Iowa Institutional Review Board.
On average, participants were 28.1 years old (standard deviation [SD] ¼ 5.7); predominately married (61.9%), White (90.4%), non-Hispanic (94.6%), and employed (66.7%); and had a mean education length of 14.6 years (SD ¼ 2.5). The average number of live births per participant was 1.85 (SD ¼ 1.0), and participants completed study measures within the 2 weeks after birth (M ¼ 13.6 days; SD ¼ 24.8 days).
Measures
Edinburgh Postnatal Depression Scale. The EPDS was developed specifically as a screening tool to assess depression symptoms in perinatal women (Cox et al., 1987) . Each of the 10 items are rated on a 4-point (range ¼ 0-3) Likert scale, referring to symptoms in the past 7 days. Item Clinically significant emotional distress expressed in the form of anxiety may be missed with an exclusive focus on depression symptoms.
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content addresses a range of symptoms, including low mood, anhedonia, guilt, and suicidal ideation. The EPDS has been validated in adult and adolescent pregnant samples and in samples of women with toddlers (Cox, Holden, & Henshaw, 2014) ; moreover, it has been shown to be internally consistent and to have moderate to good reliability across populations and languages (Boyd, Le, & Somberg, 2005) . EPDS cutoff scores to identify major depression vary across studies; however, a total EPDS score of 13 or greater is commonly used and has been shown to be optimal to identify major depression in women in the postpartum period (Matthey, Henshaw, Elliott, & Barnett, 2006) . Reliability of the EPDS in the present study sample was an alpha coefficient of .90.
Edinburgh Postnatal Depression Scale: Anxiety Subscale. A three-item anxiety subscale of the EPDS (the EPDS-A) has also been identified (Pop, Komproe, & Van Son, 1992) . The EPDS-A comprises three items from the EPDS scale described above: I have blamed myself unnecessarily when things went wrong, I have been anxious or worried for no good reason, and I have felt scared or panicky for no very good reason. This subscale was replicated in samples of antenatal and postpartum women (Brouwers, van Baar, & Pop, 2001; Jomeen & Martin, 2005 , 2007 Swalm, Brooks, Doherty, Nathan, & Jacques, 2010) and mothers of newborns in the NICU (Stasik-O'Brien, McCabe-Beane, & Segre, 2017) . The EPDS-A can be used to effectively identify perinatal women with anxiety disorder (Grigoriadis et al., 2011; Matthey, 2008; Swalm et al., 2010) , and Matthey (2008) reported that an EPDS-A score of 6 or greater was optimal for detecting panic disorder, generalized anxiety disorder (GAD), and obsessive-compulsive disorder in a community sample of postpartum women based on the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV; American Psychiatric Association, 1994). However, the extant data is less consistent with regard to how effectively scores on the EPDS-A can be used to distinguish between women with primarily anxiety versus depression symptoms; thus, further validation is necessary before recommending its widespread clinical use (Matthey, Fisher, & Rowe, 2013) . The reliability and internal consistency of the EPDS-A was shown across populations (Adouard, GlangeaudFreudenthal, & Golse, 2005; Alvarado, Jadresic, Guajardo, & Rojas, 2015; Boyd et al., 2005; Jomeen & Martin, 2007; Kernot, Olds, Lewis, & Maher, 2015; Swalm et al., 2010 ). In the current study, alpha reliability for the EPDS-A was .82.
Beck Anxiety Inventory. The Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988 ) is one of the most frequently used assessment instruments to measure anxiety across clinical and research settings (Bardhoshi, Duncan, & Erford, 2016) . It was developed to distinguish between anxiety and depression, and the items are used to address the presence and severity of the physiologic, behavioral, and affective symptoms of anxiety. The BAI includes 21 items, each rated on a 4-point (0-3) Likert scale using a past month timeframe. Total scores can range from 0 to 63; a cutoff score of 16 or greater has been suggested to identify clinically significant anxiety symptoms (Beck & Steer, 1993) . Although it was not developed specifically for use in perinatal samples, scores on the BAI have been used to identify maternal symptoms of anxiety that are sensitive to treatment in the postpartum period (de Camps Meschino, Philipp, Israel, & Vigod, 2016; Griffiths & BarkerCollo, 2008; Shaw et al., 2014) . Across studies on its psychometric properties, the BAI was internally consistent and reliable over time in clinical and nonclinical samples (de Ayala, Vonderharr-Carlson, & Kim, 2005) . The full 21-item BAI was administered in the current study, and a cutoff score of 16 or greater was used to identify elevated anxiety levels; the coefficient alpha reliability of the BAI was .91.
The Pregnancy Risk Assessment Monitoring System-Anxiety Items. The Pregnancy Risk Assessment Monitoring System-Anxiety Items (PRAMS-A; Shulman, Gilbert, & Lansky, 2006 ) is a surveillance assessment tool used by state public health departments to survey perinatal women and identify risk factors for negative outcomes in mothers and newborns. It is used in most U.S. states and is administered through state governments and the Centers for Disease Control and Prevention (CDC). The self-report survey is administered annually to a stratified sample of women who have had live births in the previous 2 to 4 months. The PRAMS questionnaire is divided into two parts: the core questionnaire and the standard questions. The core questionnaire is used by 47 participating states and includes items to assess content such as attitudes about pregnancy, substance use, physical abuse, pregnancy-related morbidity, and contraceptive use. In addition to the core questionnaire, the PRAMS standard questions are optional items that states may choose to administer, thus each state's PRAMS questionnaire is specific to that state.
In an effort to move beyond depression screening, the CDC requested consultation from the Iowa Depression and Clinical Research Center to develop items to assess anxiety in perinatal women (O'Hara et al., 2012) . Sets of candidate self-report items were evaluated against DSM-IV diagnoses of GAD. Based on sensitivity and specificity for the detection of clinical levels of anxiety, two items that assess anxiety symptoms were selected for inclusion in the PRAMS standard question battery: Since your new baby was born, how often have you felt restless? and Since your new baby was born, how often have you felt panicky? These were rated on a 5-point scale from never to always (CDC, 2012). A cutoff score of 6 or greater on these two anxiety items shows good sensitivity and specificity to identify GAD diagnoses in postpartum women (O'Hara et al., 2012) . Three states used the optional anxiety module at the time of data collection, and one state used the anxiety module in the current version of the questionnaire (CDC, 2012). Because the PRAMS anxiety items have been validated in a perinatal population but the BAI has not, the PRAMS items were included in the original feasibility trial. The PRAMS-A had a coefficient alpha reliability of .75 in the present study.
Data Analysis
Pearson's correlations were calculated to assess associations among the anxiety measures. Analyses to determine the incremental identification of emotional distress offered by anxiety screening were completed through the calculation of means, standard deviations, and frequencies of positive results on all screening measures (Table 1) .
Results
Associations among the anxiety measures ranged from r ¼ .52 (between the EPDS-A and the BAI) to r ¼ .64 (between the PRAMS-A and the BAI). The rate of positive depression screening results on the EPDS was 22.1%. Rates of positive anxiety screening results were similar to depression, with positive results for 21.6% of participants using the EPDS-A, 29.5% of participants using the PRAMS-A, and 27.9% of participants using the BAI. The addition of anxiety screening instruments to the EPDS depression screen resulted in the identification of an additional 4.7% to 14.7% of the sample who indicated elevated distress, depending on the anxiety scale used (see Table 1 ). To familiarize clinical providers with options for anxiety screening, details of practical use for the three anxiety instruments evaluated in this study are provided in Table 2 .
Discussion
In this sample of mothers of newborns hospitalized in the NICU, depression-only screening failed to identify 4.7% to 14.7% of participants with clinically significant levels of anxiety symptoms. Empirical support for the broader The addition of anxiety screening to the depression screening resulted in the identification of an additional 4.7% to 14.7% of the sample who endorsed elevated distress. psychosocial assessment of perinatal women is provided in this emerging evidence (Austin & Marcé Society Postion Statement Advisory Committee, 2014) , and the need to screen for anxiety and depression in mothers of newborns in the NICU is emphasized. Further, with the results from this study, we address a previously identified gap in the literature that pertains to the need for future research to compare different anxiety screening instruments used with perinatal women (Matthey et al., 2013) .
Distress in Mothers of Hospitalized Newborns
Consistent with recommendations from the National Perinatal Association to enhance psychological support of parents of newborns in the NICU through staff education (Hall et al., 2015) , we described the three screening instruments used in the current secondary analysis (Table 2) . For clinical providers considering the addition of anxiety screening, the following discussion outlines the relative advantages of these three tools with respect to breadth of anxiety symptom assessment, validation of the instruments in perinatal samples, and additional burden of the instrument on providers and mothers.
Breadth of Anxiety Symptom Assessment
Anxiety disorders represent a broad diagnostic category and include a range of symptoms, such as the excessive worry, panic attacks, and fear of social evaluation exemplified in GAD, panic disorder, and social anxiety disorder, respectively. The three anxiety screening tools that were available in this secondary analysis are used to assess different types of anxiety and related symptomatology. The EPDS-A cutoff scores were derived against the presence of GAD, obsessive-compulsive disorder, or panic disorder. In contrast, the PRAMS-A cutoff score was derived against the presence of GAD, only. Although the BAI cutoff score was derived against the presence of any anxiety disorder, researchers showed that the BAI may be better used to capture symptomatology consistent with panic disorder than other anxiety disorders (Leyfer, Ruberg, & Woodruff-Borden, 2006) . Therefore, selection of a screening tool should be guided by the type of anxiety the provider wants to identify.
Validation of Instruments in Perinatal Samples
As highlighted by Matthey (2008) , anxiety screening measures should be validated in perinatal women. The EPDS-A has been well validated in samples of prenatal and postpartum women, and the PRAMS-A has been validated in a large sample of postpartum women (Brouwers, van Baar, & Pop, 2001; Grigoriadis et al., 2011; Jomeen & Martin, 2005 , 2007 Matthey, 2008; O'Hara et al., 2012; Swalm et al., 2010) . In contrast, although researchers showed the validity of the BAI for use in perinatal samples (de Camps Meschino et al., 2016; Griffiths & Barker-Collo, 2008; Shaw et al., 2014) , the BAI cutoff score of 16 and greater has not yet been validated in a perinatal sample. Thus, of the instruments used in the present study, the EPDS-A is well validated in perinatal samples with a cutoff score aimed to identify the presence of multiple anxiety disorders. The PRAMS-A is well validated in a postpartum sample with a cutoff score aimed to identify the presence of GAD. The BAI cutoff score has not been validated in a perinatal sample and is likely better used to identify panic disorder than other anxiety pathology. A final important point is that none of these instruments have cutoff scores that have been validated in a sample of mothers of newborns in the NICU.
Burden on Providers and Mothers of Newborns in the NICU
Time is a critical consideration for any fast-paced clinical setting. Of these three instruments, the EPDS-A places the least additional burden on providers and mothers because the three EPDS-A items are already completed in the context of the EPDS. The PRAMS-A also incurs little additional burden because only two items are reported and scored. In contrast, the BAI contains 21 items, so it requires more time for women to complete and for providers to score.
Limitations
The evaluation of the three anxiety symptom scales presented here capitalized on an available data set gathered during the recruitment phase of a NICU-based treatment trial to evaluate a nursedelivered depression intervention. Because this study was not designed specifically to assess the utility of these scales in this population, there are a few noteworthy methodologic limitations. First, this study did not include diagnostic interviews that would have permitted the validation of cutoff scores for these anxiety screening scales in a Anxiety screening options that place minimal additional burden on providers and mothers are available.
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I N F O C U S NICU-based sample. Given that mothers of newborns in the NICU may be a population at risk of increased anxiety (Jubinville et al., 2012; Lefkowitz et al., 2010; Shaw et al., 2006) , cutoff scores derived from community samples of postpartum women may not be optimal to identify anxious mothers of newborns in the NICU. Future studies would benefit from validation of these anxiety screening scales in a NICU-based sample by including diagnostic interviews and identifying optimal cutoff scores for this population at risk for anxiety and to more rigorously compare these instruments against clinical diagnoses to inform recommendations for screening in the NICU. Further, although symptoms of acute stress disorder (ASD) are prevalent in this population of mothers soon after newborn hospitalization (Jubinville et al., 2012; Lefkowitz et al., 2010; Shaw et al., 2006) , this aspect of emotional distress was not assessed in the data set for this secondary analysis. Because acute stress disorder is no longer categorized as an anxiety disorder (American Psychiatric Association, 2013), limiting screening to depression and anxiety symptoms may mean that the trauma component of emotional distress is missed. This omission is a significant limitation of the current study and an important direction for future research. A final limitation pertains to the demographically homogenous sample included in these analyses, such that racial and ethnic minorities and women with lower levels of education were not represented in the present analyses.
Conclusions
In conclusion, results from this study showed that the addition of anxiety screening scales helped to identify emotionally distressed women who would have been missed during routine depression-only screening. Specifically, during the 17-month period of recruitment for our treatment trial, and depending on the anxiety screening scale used, adding anxiety screening helped to identify an additional 4.7% to 14.7% of the sample who endorsed elevated distress. These results underscore two important take-home points. First, the women who were identified through anxiety screening experienced clinically significant emotional distress, which would otherwise not have been identified. Second, the addition of anxiety screening would not overwhelm health care providers in terms of the number of women who require further assessment. A formal recommendation for anxiety screening has not yet been issued, and in the NICU context specifically, there is an urgent need to validate cutoff points for anxiety measures. Nevertheless, in the absence of formal recommendations and validated cutoff points, cautious incorporation of anxiety screening may simultaneously serve the clinical needs of mothers of newborns in the NICU and provide the practice-based evidence needed to formally evaluate the effectiveness and benefit of this practice.
